Pharmaceutical computational chemists leverage advanced computational techniques and molecular modeling tools to accelerate drug discovery and development. By simulating molecular interactions, predicting chemical properties, and designing novel compounds, they help identify promising drug candidates before costly laboratory synthesis and testing. These scientists use methods such as molecular docking, quantum mechanics, and molecular dynamics to understand the behavior of drug molecules and their targets at the atomic level. Their work significantly reduces the time and cost associated with bringing new medications to market, improving efficiency in pharmaceutical research.
Pharmaceutical computational chemists analyze the pharmacokinetics and toxicity profiles of compounds using in silico models, helping to predict how drugs will behave in the human body. They collaborate closely with medicinal chemists, biologists, and pharmacologists to optimize drug candidates and guide experimental efforts. As artificial intelligence and machine learning technologies advance, computational chemists increasingly integrate these tools to enhance predictive accuracy and streamline drug development pipelines. Their expertise is crucial in bridging theoretical chemistry and practical application, driving innovation and improving the success rate of new therapeutic agents. Their contributions are pivotal in shaping the future of personalized medicine and targeted therapies. Furthermore, their work supports the pharmaceutical industry’s efforts to meet evolving regulatory requirements and market demands.
Title : The impact of metal-decorated polymeric nanodots on proton relaxivity
Paulo Cesar De Morais, Catholic University of Brasilia, Brazil
Title : Hepatotoxic botanicals-shadows of pearls
Consolato M Sergi, Universities of Alberta and Ottawa, Canada
Title : Exploring classical ayurvedic drugs in hypertension
Prashant Bhokardankar, Datta Meghe Ayurved College, India
Title : Principles and standards for managing healthcare transformation towards personalized, preventive, predictive, participative precision medicine ecosystems
Bernd Blobel, University of Regensburg, Germany
Title : Personalized and Precision Medicine (PPM) as a unique healthcare model based on design-inspired biotech- & biopharma-driven applications to secure the human healthcare and biosafety
Sergey Suchkov, N.D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences & InMedStar, Russian Federation
Title : A unique role and and impact of catalytic antibodies (abzymes) in clinical practice: A novel strategy for predicting and preventing relapse in chronic autoimmune conditions
Sergey Suchkov, N.D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences & InMedStar, Russian Federation
Title : The promise of nanotechnology in personalized & precision medicine: Drug discovery & development being partnered with nanotechnologies via the revolution at the nanoscale
Sergey Suchkov, N.D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences & InMedStar, Russian Federation
Title : The promising future of the unique translational tool to manage beta-cell population renewal and regeneration to secure the post-diabetic period
Sergey Suchkov, N.D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences & InMedStar, Russian Federation
Title : Easily injectable, organic solvent free self assembled hydrogel platform for endoscope mediated gastrointestinal polypectomy
Hitasha Vithalani , IIT Gandhinagar, India